Key takeaways
- ·In 2026, supplier choice is a research-quality decision and a continuity decision. A supplier that fails on testing undermines your data; one that fails on compliance can disappear overnight.
- ·The FDA's March 2026 warning letters show what non-compliant sellers look like.[1][2][3] Use them as a negative checklist.
- ·The strongest positive signal is batch-specific, independently verifiable analytical data covering identity, purity and content.

